New synthetic molecules could transform cannabis treatment
Pharma companies can’t make reliable, consistent drugs from cannabis plant compounds. EPM’s synthetic cannabis acid molecules could make it possible.
Pharma companies can’t make reliable, consistent drugs from cannabis plant compounds. EPM’s synthetic cannabis acid molecules could make it possible.
Investors, researchers and high-tech experts gather for Israel’s first International Summit for Accelerating Cannabis Innovation.
‘Working in a small country certainly has its positive aspects,’ Raphael Mechoulam says. ‘It couldn’t have happened in the United States.’